Hrt Financial LP Monte Rosa Therapeutics, Inc. Transaction History

Hrt Financial LP

  • $15.7 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$3.59 - $6.97 $139,690 - $271,209
38,911 New
38,911 $206,000
Q4 2023

Feb 09, 2024
BUY
$2.5 - $5.93 $131,275 - $311,384
52,510 Added 491.02%
63,204 $357,000
Q3 2023

Nov 13, 2023
BUY
$4.78 - $7.22 $51,117 - $77,210
10,694 New
10,694 $51,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $615,171 - $1.04 Million
85,798 New
85,798 $700,000

Others Institutions Holding GLUE

# of Institutions
102
Shares Held
49.1M
Call Options Held
285K
Put Options Held
31.2K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $317M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email